Brookfield Corp’s Synovus SNV Stock Holding History

Brookfield Corp’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-201,779	Closed	-$6.22M	–	738
2023 Q1	$6.22M	Buy	+201,779	New	+$7.68M	0.02%	252
2022 Q1	–	Sell	-123,913	Closed	-$5.93M	–	773
2021 Q4	$5.93M	Sell	123,913 -17,563	-12%	-$832K	0.02%	195
2021 Q3	$6.21M	Buy	141,476 +60,214	+74%	+$2.55M	0.02%	190
2021 Q2	$3.57M	Buy	+81,262	New	+$3.82M	0.02%	265

Other funds holding SNV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Brookfield Corp's SNV Position: Q2 2023 in Review

Brookfield Corp sold out of Synovus (SNV) in Q2 2023, closing a stake of 201,779 shares — an estimated $6.22M sold.

Brookfield Corp first reported a position in SNV in Q2 2021 and held it in 4 quarters. The position peaked at $6.22M in Q1 2023. 370 funds tracked by Wall St. Rank hold SNV as of Q2 2023.

Brookfield Corp reported no remaining Synovus position as of Q2 2023 after selling out during the quarter.
Brookfield Corp sold 201,779 Synovus shares in Q2 2023, an estimated $6.22M.
Brookfield Corp first reported a position in Synovus in Q2 2021 and held it in 4 quarters.
Brookfield Corp's Synovus position peaked at $6.22M in Q1 2023.
370 funds tracked by Wall St. Rank held Synovus as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.